Literature DB >> 5487026

The effects of caerulein on insulin secretion in anaesthetized dogs.

G Bertaccini, G De Caro, P Melchiorri.   

Abstract

1. Insulin concentration changes in pancreatico-duodenal venous plasma were studied in anaesthetized dogs injected with caerulein.2. Rises in insulin concentration were elicited by rapid intravenous injection of caerulein, as well as by intravenous infusion. Threshold doses were 10 ng/kg and 0.5-1 (ng/kg)/min respectively.3. At the highest dose used (500 ng/kg by rapid intravenous injection and (25 ng/kg)/min by intravenous infusion) the increase in immuno-reactive insulin release was approximately 7 to 9 times the base levels.4. Adrenalectomy potentiated the effects of intravenous infusion of caerulein.5. On a molar basis, caerulein was 2-3 times as active as pancreozymin.6. It is concluded that caerulein is a potent stimulant of pancreatic islets in the dog and that it may be considered as a model peptide, capable of being substituted for pancreozymin in any experiment.7. The mechanism of the insulin stimulating effect of caerulein is discussed. The possibility of a direct "beta-cytotropic" effect of the peptide is suggested.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5487026      PMCID: PMC1702666          DOI: 10.1111/j.1476-5381.1970.tb10612.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Dynamics of insulin secretion by the perfused rat pancreas.

Authors:  D L Curry; L L Bennett; G M Grodsky
Journal:  Endocrinology       Date:  1968-09       Impact factor: 4.736

3.  Isolation and amino acid sequence of caerulein, the active decapeptide of the skin of hyla caerulea.

Authors:  A Anastasi; V Erspamer; R Endean
Journal:  Arch Biochem Biophys       Date:  1968-04       Impact factor: 4.013

4.  Comparative effects of caerulein, pancreozymin and secretin on pancreatic blood flow.

Authors:  L Dorigotti; A H Glässer
Journal:  Experientia       Date:  1968-08-15

5.  Effect of pancreozymin on insulin and glucagon levels in blood and bile.

Authors:  K D Buchanan; J E Vance; A Morgan; R H Williams
Journal:  Am J Physiol       Date:  1968-12

6.  Stimulation of insulin secretion by pancreozymin.

Authors:  R C Meade; H A Kneubuhler; W J Schulte; J J Barboriak
Journal:  Diabetes       Date:  1967-03       Impact factor: 9.461

7.  Insulin output via the pancreatic vein and plasma insulin response to glucose in dogs.

Authors:  Y Kanazawa; T Kuzuya; T Ide
Journal:  Am J Physiol       Date:  1968-09

8.  The action of caerulein on pancreatic secretion of the dog and biliary secretion of the dog and the rat.

Authors:  G Bertaccini; G De Caro; R Endean; V Erspamer; M Impicciatore
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

9.  The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs.

Authors:  R H Unger; H Ketterer; J Dupré; A M Eisentraut
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

10.  The actions of caerulein on the smooth muscle of the gastrointestinal tract and the gall bladder.

Authors:  G Bertaccini; G De Caro; R Endean; V Erspamer; M Impicciatore
Journal:  Br J Pharmacol       Date:  1968-10       Impact factor: 8.739

View more
  3 in total

1.  Active polypeptides in amphibian skin.

Authors:  G Bertaccini
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

2.  The mechanism of insulin secretion after oral glucose administration. I. Multiphasic course of insulin mobilization after oral administration of glucose in conscious dogs. Differences to the behaviour after intravenous administration.

Authors:  U Fischer; H Hommel; M Ziegler; R Michael
Journal:  Diabetologia       Date:  1972-04       Impact factor: 10.122

3.  The effects of caerulein on exocrine pancreatic secretion in pigs.

Authors:  C Belloli; P Ormas; S Cissokho; C Beretta
Journal:  Vet Res Commun       Date:  1983-01       Impact factor: 2.459

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.